Corundum Group, Inc. Abb Vie Inc. Transaction History
Corundum Group, Inc.
- $218 Million
- Q3 2024
A detailed history of Corundum Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Corundum Group, Inc. holds 5,022 shares of ABBV stock, worth $875,987. This represents 0.45% of its overall portfolio holdings.
Number of Shares
5,022
Previous 9,233
45.61%
Holding current value
$875,987
Previous $1.58 Million
37.4%
% of portfolio
0.45%
Previous 0.62%
Shares
19 transactions
Others Institutions Holding ABBV
# of Institutions
3,795Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$29.8 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$13.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.09 Billion0.84% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$6.73 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $308B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...